411
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database

, , , , , & show all
Pages 655-665 | Accepted 31 Jan 2014, Published online: 27 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Laszlo Mark, György Paragh & Kausik K. Ray. (2017) The need for a new classification of cholesterol lowering therapies. Current Medical Research and Opinion 33:1, pages 67-69.
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2014) Achieving lipid targets in primary care settings. Current Medical Research and Opinion 30:10, pages 1971-1974.
Read now

Articles from other publishers (6)

Sergiu-Ciprian Matei. 2023. Statins - From Lipid-Lowering Benefits to Pleiotropic Effects. Statins - From Lipid-Lowering Benefits to Pleiotropic Effects.
Sergiu-Ciprian Matei, Mervat Matei, Flavia Medana Anghel, Mihnea Dragoș Derban, Andra Olariu & Sorin Olariu. (2021) Impact of statin treatment on patients diagnosed with chronic venous disease. Morphological analysis of the venous wall and clinical implications. Phlebology: The Journal of Venous Disease 37:3, pages 188-195.
Crossref
Orlando Rosa, Adriana C. Flores‐Gallegos, Juan A. Ascacio‐Valdés, Leonardo Sepúlveda, Julio C. Montáñez & Cristóbal N. Aguilar. 2022. Probiotics, Prebiotics and Synbiotics. Probiotics, Prebiotics and Synbiotics 307 337 .
Iryna Dykun, Daniela Wiefhoff, Matthias Totzeck, Fadi Al-Rashid, R. Alexander Jánosi, Tienush Rassaf & Amir A. Mahabadi. (2019) Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease. IJC Heart & Vasculature 22, pages 73-77.
Crossref
Kevin Fitzgerald, Suellen White, Anna Borodovsky, Brian R. Bettencourt, Andrew Strahs, Valerie Clausen, Peter Wijngaard, Jay D. Horton, Jorg Taubel, Ashley Brooks, Chamikara Fernando, Robert S. Kauffman, David Kallend, Akshay Vaishnaw & Amy Simon. (2017) A Highly Durable RNAi Therapeutic Inhibitor of PCSK9. New England Journal of Medicine 376:1, pages 41-51.
Crossref
Ulrich Laufs, Barbara Karmann & David Pittrow. (2016) Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk. Clinical Research in Cardiology 105:9, pages 783-790.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.